RA (n=37) SpA (n=53) CD (n=47)
Positive total ADAbs, n (%) 13 (35) 21 (39) 10 (21)
Positive ADAbs anti IFX, n 8 11 8
Positive ADAbs anti ADA, n 5 10 2
Mean anti-IFX ADAbs rate (UI/ml) 15.7 [0-200] 60.5 [0-200] 0.7 [0-200]
Mean anti-ADA ADAbs rate (UI/ml) 5.61 [0.64-111] 6.5 [0-405] 5.69 [0-405]
Mean IFX residual dose rate (µg/ml) 0.43 [0.23-3] 0.54 [0-9.5] 1.5 [0-5.67]
Mean ADA residual dose rate (µg/ml) 5.06 [0-8] 5.9 [0-9.32] 4.85 [0-7.85]